ACADIA Pharmaceuticals
ACAD
#3988
Rank
A$4.78 B
Marketcap
A$27.67
Share price
3.36%
Change (1 day)
-24.69%
Change (1 year)

Earnings for ACADIA Pharmaceuticals (ACAD)

Earnings in 2026 (TTM): A$0.22 Billion

According to ACADIA Pharmaceuticals's latest financial reports the company's current earnings are A$1.20 Billion. In 2025 the company made an earning of A$0.20 Billion a decrease over its 2024 earnings that were of A$0.38 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for ACADIA Pharmaceuticals from 2003 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) A$0.22 B11.29%
2025 A$0.20 B-46.18%
2024 A$0.38 B-605.67%
2023 -A$75.31 Million-76.09%
2022 -A$0.32 Billion27.41%
2021 -A$0.25 Billion-40.38%
2020 -A$0.42 Billion19.88%
2019 -A$0.35 Billion-3.92%
2018 -A$0.36 Billion-15.04%
2017 -A$0.43 Billion6.33%
2016 -A$0.4 Billion64.55%
2015 -A$0.25 Billion77.47%
2014 -A$0.14 Billion143.69%
2013 -A$56 Million81.93%
2012 -A$30.78 Million-8.73%
2011 -A$33.72 Million-251.39%
2010 A$22.27 M-133.2%
2009 -A$67.09 Million-30.82%
2008 -A$96.98 Million6.43%
2007 -A$91.12 Million25.89%
2006 -A$72.38 Million36.99%
2005 -A$52.84 Million37.22%
2004 -A$38.51 Million19.96%
2003 -A$32.1 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
A$27.62 B 11,808.12%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
A$10.28 B 4,332.23%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
A$51.30 B 22,016.12%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
A$16.72 B 7,108.10%๐Ÿ‡บ๐Ÿ‡ธ USA
Vanda Pharmaceuticals
VNDA
-A$0.27 Billion-213.16%๐Ÿ‡บ๐Ÿ‡ธ USA
Adamas Pharmaceuticals
ADMS
-A$57 Million-124.57%๐Ÿ‡บ๐Ÿ‡ธ USA